CBMG completes Wuxi stem cell plant expansion – BioPharma-Reporter.com
|
CBMG completes Wuxi stem cell plant expansion
BioPharma-Reporter.com The firm said: “By the end of 2017, the Company anticipates that the combination of this Wuxi site, the new Zhangjiang Shanghai and the Beijing GMP facilities will be capable of supporting simultaneous clinical trials for five different CAR-T and stem … |
